Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-25

Clinical Trial Update: Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating whether calcium and magnesium infusions can prevent paclitaxel-induced neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium and Magnesium Infusion (calcium and magnesium infusion)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Paclitaxel-induced Neuropathy | Phase 1 | Status: COMPLETED